Structure-Immunogenicity Relationships of Therapeutic Proteins
Top Cited Papers
- 1 June 2004
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 21 (6), 897-903
- https://doi.org/10.1023/b:pham.0000029275.41323.a6
Abstract
As more recombinant human proteins become available on the market, the incidence of immunogenicity problems is rising. The antibodies formed against a therapeutic protein can result in serious...Keywords
This publication has 40 references indexed in Scilit:
- Drug-Induced Autoimmune Red-Cell AplasiaNew England Journal of Medicine, 2002
- Peginterferon-??-2a (40kD)Drugs, 2001
- Induction of Autoantibodies to Different Interleukin-2 AllotypesJournal of Autoimmunity, 1999
- Secondary Structure and Protein DeamidationJournal of Pharmaceutical Sciences, 1999
- Interferon immunogenicity: technical evaluation of interferon-alpha 2a.1997
- The Influence of Antigen Organization on B Cell ResponsivenessScience, 1993
- Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteinsProtein Engineering, Design and Selection, 1991
- Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSFThe Lancet, 1990
- TRANSGENIC MICE AS A MODEL TO TEST THE IMMUNOGENICITY OF PROTEINS ALTERED BY SITE-SPECIFIC MUTAGENESIS1989
- Role of Aggregated Human Growth Hormone (hGH) in Development of Antibodies to hGH*Journal of Clinical Endocrinology & Metabolism, 1980